DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr. Reddy's Laboratories
02 1Biophore India Pharmaceuticals Pvt Ltd
03 1ALP Pharm
04 1Alembic Pharmaceuticals Limited
05 1Cambrex Corporation
06 1Cipla
07 1Glenmark Life Sciences
08 1Hetero Drugs
09 1MSN Laboratories
10 1Olon S.p.A
11 1ScinoPharm Taiwan, Ltd
12 1Shandong Anhong Pharmaceutical
13 1Wisdom Pharmaceutical
01 12OLAPARIB
02 1OLAPARIB FORM A
01 3China
02 7India
03 1Italy
04 1Taiwan
05 1U.S.A
01 13Active
01 7Complete
02 6Blank
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
GDUFA
DMF Review : Complete
Rev. Date : 2022-04-19
Pay. Date : 2022-03-31
DMF Number : 35742
Submission : 2021-03-30
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40467
Submission : 2024-09-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-05-31
Pay. Date : 2018-02-22
DMF Number : 32505
Submission : 2018-03-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 31219
Submission : 2016-12-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2022-08-29
Pay. Date : 2022-08-10
DMF Number : 37240
Submission : 2022-08-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35831
Submission : 2021-04-17
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-10-12
Pay. Date : 2023-08-29
DMF Number : 34698
Submission : 2020-03-31
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-21
Pay. Date : 2022-12-22
DMF Number : 37779
Submission : 2023-02-09
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-11-16
Pay. Date : 2018-09-27
DMF Number : 32629
Submission : 2018-04-20
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 38136
Submission : 2023-03-01
Status : Active
Type : II
A Olaparib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Olaparib, including repackagers and relabelers. The FDA regulates Olaparib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Olaparib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Olaparib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Olaparib supplier is an individual or a company that provides Olaparib active pharmaceutical ingredient (API) or Olaparib finished formulations upon request. The Olaparib suppliers may include Olaparib API manufacturers, exporters, distributors and traders.
click here to find a list of Olaparib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Olaparib DMF (Drug Master File) is a document detailing the whole manufacturing process of Olaparib active pharmaceutical ingredient (API) in detail. Different forms of Olaparib DMFs exist exist since differing nations have different regulations, such as Olaparib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Olaparib DMF submitted to regulatory agencies in the US is known as a USDMF. Olaparib USDMF includes data on Olaparib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Olaparib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Olaparib suppliers with USDMF on PharmaCompass.
We have 13 companies offering Olaparib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?